Literature DB >> 17952639

Distribution of peripherally injected peptide YY ([125I] PYY (3-36)) and pancreatic polypeptide ([125I] hPP) in the CNS: enrichment in the area postrema.

Yvan Dumont1, Emmanuel Moyse, Alain Fournier, Rémi Quirion.   

Abstract

The mechanism by which blood-borne peptide YY (3-36) (PYY(3-36)) and pancreatic polypeptide (PP) inhibit food intake is not clear and could implicate peripheral (vagal afferent pathways) and/or central (direct action on specific brain nuclei) mechanisms. To identify the primary brain structure(s) that could be activated after a peripheral injection of neuropeptide Y-related peptides, we investigated the distribution of radioactive materials using whole body autoradiography and coronal brain sections. Rats were injected with [125I] porcine (p) PYY(3-36) (i.p., 10 microCi) and killed after 30 min, 1, 2, or 4 h. After i.p. administration, significant amounts of radioactive materials were rapidly (<30 min) detected in the blood circulation and various tissues including the kidneys, liver, lung, heart, bone marrow, gastrointestinal tract, and thyroid gland, whereas in the brain, low but significant amounts of radioactive materials were detected at the level of the area postrema. Next, we investigated the distribution of radioactive labeling in the brain after i.v. injections of [125I]pPYY(3-36) (Y2 and Y5 subtypes), [125I] human (h) PP (Y4 and Y5 receptors), and [125I][Leu(31), Pro(34)] pPYY (Y1, Y4 and Y5 classes) in the rat brain. Fifteen minutes post injection, autoradiograms revealed positive signals only in the area postrema after the injection of [125I]-hPP and [125I][Leu(31), Pro(34)]pPYY. Whereas the presence of [125I]pPYY(3-36)-related labeling was detected in the area postrema, subfornical organ, and median eminence. In all other brain structures, including all hypothalamic nuclei and other circumventricular organs, near background level signals were detected. These data suggest that the inhibition of food intake observed after peripheral injections of pPYY(3-36) and hPP could involve receptor activation preferentially located at the level of the area postrema, a structure well-known to be involved in the modulation of food intake.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17952639     DOI: 10.1007/s12031-007-9007-9

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  66 in total

1.  [(125)I]-GR231118: a high affinity radioligand to investigate neuropeptide Y Y(1) and Y(4) receptors.

Authors:  Y Dumont; R Quirion
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

2.  Pancreatic polypeptide: a possible role in the regulation of food intake in the mouse. Hypothesis.

Authors:  F Malaisse-Lagae; J L Carpentier; Y C Patel; W J Malaisse; L Orci
Journal:  Experientia       Date:  1977-07-15

Review 3.  Neuropeptide Y receptors: autoradiographic distribution in the brain and structure-activity relationships.

Authors:  R Quirion; J C Martel; Y Dumont; A Cadieux; F Jolicoeur; S St-Pierre; A Fournier
Journal:  Ann N Y Acad Sci       Date:  1990       Impact factor: 5.691

Review 4.  Peptide YY in gastrointestinal disorders.

Authors:  Magdy El-Salhy; Ole Suhr; Ake Danielsson
Journal:  Peptides       Date:  2002-02       Impact factor: 3.750

5.  The novel neuropeptide Y Y(1) receptor antagonist J-104870: a potent feeding suppressant with oral bioavailability.

Authors:  A Kanatani; T Kanno; A Ishihara; M Hata; A Sakuraba; T Tanaka; Y Tsuchiya; T Mase; T Fukuroda; T Fukami; M Ihara
Journal:  Biochem Biophys Res Commun       Date:  1999-12-09       Impact factor: 3.575

6.  Neuropeptide Y--a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide.

Authors:  K Tatemoto; M Carlquist; V Mutt
Journal:  Nature       Date:  1982-04-15       Impact factor: 49.962

7.  Gut hormone PYY(3-36) physiologically inhibits food intake.

Authors:  Rachel L Batterham; Michael A Cowley; Caroline J Small; Herbert Herzog; Mark A Cohen; Catherine L Dakin; Alison M Wren; Audrey E Brynes; Malcolm J Low; Mohammad A Ghatei; Roger D Cone; Stephen R Bloom
Journal:  Nature       Date:  2002-08-08       Impact factor: 49.962

8.  Peripheral peptide YY induces c-fos-like immunoreactivity in the rat brain.

Authors:  B Bonaz; I Taylor; Y Taché
Journal:  Neurosci Lett       Date:  1993-11-26       Impact factor: 3.046

Review 9.  Effects and consequences of nerve injury on the electrical properties of sensory neurons.

Authors:  Fuad A Abdulla; Timothy D Moran; Sridhar Balasubramanyan; Peter A Smith
Journal:  Can J Physiol Pharmacol       Date:  2003-07       Impact factor: 2.273

10.  Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats.

Authors:  J T Clark; P S Kalra; W R Crowley; S P Kalra
Journal:  Endocrinology       Date:  1984-07       Impact factor: 4.736

View more
  14 in total

Review 1.  Brainstem neuropeptides and vagal protection of the gastric mucosal against injury: role of prostaglandins, nitric oxide and calcitonin-gene related peptide in capsaicin afferents.

Authors:  Y Tache
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

Review 2.  Obesity treatment: novel peripheral targets.

Authors:  Benjamin C T Field; Owais B Chaudhri; Stephen R Bloom
Journal:  Br J Clin Pharmacol       Date:  2009-12       Impact factor: 4.335

Review 3.  Central nervous system control of gastrointestinal motility and secretion and modulation of gastrointestinal functions.

Authors:  Kirsteen N Browning; R Alberto Travagli
Journal:  Compr Physiol       Date:  2014-10       Impact factor: 9.090

4.  C-terminal motif of human neuropeptide Y4 receptor determines internalization and arrestin recruitment.

Authors:  Lizzy Wanka; Stefanie Babilon; Kerstin Burkert; Karin Mörl; Vsevolod V Gurevich; Annette G Beck-Sickinger
Journal:  Cell Signal       Date:  2016-11-03       Impact factor: 4.315

Review 5.  Anxiety, Depression, and the Microbiome: A Role for Gut Peptides.

Authors:  Gilliard Lach; Harriet Schellekens; Timothy G Dinan; John F Cryan
Journal:  Neurotherapeutics       Date:  2018-01       Impact factor: 7.620

6.  Pharmacokinetics, adverse effects and tolerability of a novel analogue of human pancreatic polypeptide, PP 1420.

Authors:  Tricia M Tan; Benjamin C T Field; James S Minnion; Joyceline Cuenco-Shillito; Edward S Chambers; Sagen Zac-Varghese; Charlie J Brindley; Shahrul Mt-Isa; Francesca Fiorentino; Deborah Ashby; Ian Ward; Mohammad A Ghatei; Stephen R Bloom
Journal:  Br J Clin Pharmacol       Date:  2012-02       Impact factor: 4.335

7.  Peptide YY3-36 and 5-hydroxytryptamine mediate emesis induction by trichothecene deoxynivalenol (vomitoxin).

Authors:  Wenda Wu; Melissa A Bates; Steven J Bursian; Brenna Flannery; Hui-Ren Zhou; Jane E Link; Haibin Zhang; James J Pestka
Journal:  Toxicol Sci       Date:  2013-03-01       Impact factor: 4.849

8.  Increased novelty-induced motor activity and reduced depression-like behavior in neuropeptide Y (NPY)-Y4 receptor knockout mice.

Authors:  R O Tasan; S Lin; A Hetzenauer; N Singewald; H Herzog; G Sperk
Journal:  Neuroscience       Date:  2008-12-09       Impact factor: 3.590

9.  Reduced anxiety-like and depression-related behavior in neuropeptide Y Y4 receptor knockout mice.

Authors:  E Painsipp; T Wultsch; M E Edelsbrunner; R O Tasan; N Singewald; H Herzog; P Holzer
Journal:  Genes Brain Behav       Date:  2008-07       Impact factor: 3.449

10.  Regulation of hindbrain Pyy expression by acute food deprivation, prolonged caloric restriction, and weight loss surgery in mice.

Authors:  C Gelegen; K Chandarana; A I Choudhury; H Al-Qassab; I M Evans; E E Irvine; C B Hyde; M Claret; F Andreelli; S E Sloan; A B Leiter; D J Withers; R L Batterham
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-07-03       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.